Depression and anxiety in hematological cancer patient: Prevalence and associated factors

Background. - Anxiety and depression in cancer patients are associated with impaired well-being and overall quality of life. Objectives. - To study the prevalence of depression and anxiety in patients with hematological cancer, and to assess the relationship between various demographic, behavioral and clinical factors and anxiety and depression among hematological cancer patients.Methods. - This cross-sectional study recruited 159 diagnosed hematological cancer patients and 182 participants without cancer (control group) in the University hospital center Ibn Rochd of Casablanca, Morocco. Study participants fulfilled the Hospital anxiety and depression scale (HADS) and demographic and cancer characteristics.Results. - The mean age of hematological cancer patients was 43.9 years (SD = 13.8 years), while the mean age of the control group was 45.3 years (SD = 15.4 years). Using a cut-off score of 8 on HADS, anxiety and depression were found in 78.6% of hematological cancer patients against only 35.1% in control group. Logistic regression analysis revealed that anxiety and depression were associated with age under 40 years.Conclusion. - Hematological cancer patients are in high risk to develop depression and anxiety. An age less than 40 years can be a predicting factor related with depression and anxiety in hematological cancer patients.(c) 2021 Elsevier Masson SAS. All rights reserved.